Real-Time EquityWire is available only to registered users. This is best for professional traders and people who track markets actively.Real-Time EquityWire is available only to registered users. This is best for professional traders and people who track markets actively.
An expected double-digit growth in the specialty products business, steady domestic sales, and moderate performance in the US market are likely to help Sun Pharmaceutical Industries Ltd. post healthy year-on-year earnings for the March quarter, according to analysts.
Share this Story:
